ANTIHYPERTENSIVE EFFICACY OF FIXED COMBINATION AZILSARTAN MEDOXOMIL/CHLORTHALIDONE IN PATIENTS WITH UNCONTROLLED ARTERIAL HYPERTENSION

被引:0
|
作者
Kobalava, Zh. D. [1 ]
Villevalde, S. V. [1 ]
Kulakov, V. V. [1 ]
机构
[1] RUDN Univ, Peoples Friendship Univ Russia, Moscow, Russia
关键词
azilsartan medoxomil; chlorthalidone; ambulatory blood pressure monitoring; efficacy; safety; BLOOD-PRESSURE; MEDOXOMIL; CHLORTHALIDONE; HYDROCHLOROTHIAZIDE; MANAGEMENT; VALSARTAN;
D O I
10.10087/cardio.2017.11.10049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study effects of a fixed azilsartan medoxomil/chlorthalidone combination (Edarbi Clo) on clinical, ambulatory and central blood pressure (BP) in patients with uncontrolled arterial hypertension (AH)). Materials and methods. Patients (n=25) with uncontrolled AH were given fixed azilsartan medoxomil/chlorthalidone combination (40/12.5 mg/day) for 4 weeks. After 4 weeks, in patients who did not achieve target BP levels the dose was increased up to 40/25 mg/day. Duration of the study was 12 weeks. Results. After 12 weeks of treatment 88% of patients achieved target clinical BP (< 140/90 mm Hg without diabetes, < 140/85 mm Hg with diabetes). According to 24-hour blood pressure monitoring (ABPM) decline of mean BP was 19.3/11.1 mm Hg, of mean daytime peripheral BP - 20.1/11.4 mm Hg, of mean nocturnal peripheral BP - 19.5/9.1 mm Hg, of central systolic (S), diastolic and pulse BP - 15.8, 10.1, 6.6 mm Hg, respectively. Target values of mean 24-hour BP were achieved in 40% of patients. Improvement of ABPM parameters led to normalization of the daily systolic BP index, associated with increase of the portion of "dippers" (from 60 to 64%) and reduction of that of "night-pickers" at the account of their transition into "non-dipper" and "dipper" categories. There were no adverse events either causing discontinuation after the first dose or serious. Conclusion. In patients with uncontrolled AP with/without diabetes therapy with fixed- azilsartan medoxomil/chlorthalidone combination was accompanied by pronounced antihypertensive effect (lowering of clinical, daily peripheral BP, improvement of the daily SBP profile). For the first time, the effectiveness of azilsartan medoxomil/chlorthalidone combination was demonstrated in relation to the central systolic, diastolic and pulse BP. Significant changes of parameters of carbohydrate or lipid metabolism, adverse events leading to drug discontinuation were not registered.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [21] Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes
    Kochergina, A. M.
    Barbarash, O. L.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (05) : 520 - 527
  • [22] Ultra HPLC Method for Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone: Identification and in silico Toxicity Prediction of Degradation Products
    Samanthula, Gananadhamu
    Swain, Debasish
    Sahu, Gayatri
    Bhagat, Shweta
    Bharatam, P. V.
    JOURNAL OF ANALYTICAL CHEMISTRY, 2018, 73 (06) : 560 - 569
  • [24] Ultra HPLC Method for Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone: Identification and in silico Toxicity Prediction of Degradation Products
    Gananadhamu Samanthula
    Debasish Swain
    Gayatri Sahu
    Shweta Bhagat
    P. V. Bharatam
    Journal of Analytical Chemistry, 2018, 73 : 560 - 569
  • [25] Comparative Efficacy of Single Pill Combinations of Azilsartan Medoxomil/Chlorthalidone and Losartan/Hydrochlorothiazide in Patients with Hypertension and Heart Failure with Preserved Ejection Fraction
    Kobalava, Z. D.
    Safarova, A. F.
    Gudieva, H. M.
    Markova, M. A.
    Petrosyan, A. E.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2022, 18 (02) : 127 - 134
  • [26] Pharmacokinetic-pharmacodynamic modeling of the antihypertensive interaction between azilsartan medoxomil and chlorthalidone in spontaneously hypertensive rats
    Puttrevu, Santosh Kumar
    Ramakrishna, Rachumallu
    Bhateria, Manisha
    Jain, Moon
    Hanif, Kashif
    Bhatta, Rabi Sankar
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 (05) : 457 - 470
  • [27] FIXED HIGH-DOSE TRIPLE COMBINATION ANTIHYPERTENSIVE MEDICATION IN PATIENTS WITH UNCONTROLLED HYPERTENSION
    Matova, Olena
    Mishchenko, Larysa
    Serbeniyk, Katerina
    JOURNAL OF HYPERTENSION, 2021, 39 : E382 - E382
  • [28] Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk
    Korennova, Olga Yu.
    Podolnaya, Svetlana P.
    Prihodko, Ekaterina P.
    Turusheva, Elena A.
    Starinskaya, Snezhana N.
    Bratishko, Irina A.
    Druk, Inna V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2018, 14 (06) : 840 - 845
  • [29] The effect of education on the improvement of therapeutic efficacy in patients with arterial hypertension taking fixed combination of antihypertensive agents
    Dziwura-Ogonowska, Joanna
    Hajduk, Anna
    Miazgowski, Tomasz
    Tykarski, Andrzej
    Widecka, Krystyna
    ARTERIAL HYPERTENSION, 2013, 17 (04): : 314 - 321
  • [30] EFFECT OF FIXED TRIPLE ANTIHYPERTENSIVE COMBINATION THERAPY ON ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION
    Yusupova, Khafiza Furkat Qizi
    Abdullaeva, Guzal Jaloliddinovna
    Shukurova, Dilafruz Yusupovna
    Khamidullaeva, Gulnoz Abdusattarovna
    Sadullaeva, Mohinur A.
    Mashkurova, Zarina Tulkunovna
    Masharipov, Shukhrat Matkarimovich
    JOURNAL OF HYPERTENSION, 2023, 41 : E392 - E392